Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 263

Similar articles for PubMed (Select 16899600)

1.

A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer.

Schulz S, Hyslop T, Haaf J, Bonaccorso C, Nielsen K, Witek ME, Birbe R, Palazzo J, Weinberg D, Waldman SA.

Clin Cancer Res. 2006 Aug 1;12(15):4545-52.

2.

Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer.

Cagir B, Gelmann A, Park J, Fava T, Tankelevitch A, Bittner EW, Weaver EJ, Palazzo JP, Weinberg D, Fry RD, Waldman SA.

Ann Intern Med. 1999 Dec 7;131(11):805-12.

PMID:
10610624
3.

Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.

Frick GS, Pitari GM, Weinberg DS, Hyslop T, Schulz S, Waldman SA.

Expert Rev Mol Diagn. 2005 Sep;5(5):701-13. Review.

PMID:
16149873
5.

Analytical performance of a qRT-PCR assay to detect guanylyl cyclase C in FFPE lymph nodes of patients with colon cancer.

Beaulieu M, Desaulniers M, Bertrand N, Deschesnes RG, Beaudry G, Garon G, Haince JF, Houde M, Holzer TJ.

Diagn Mol Pathol. 2010 Mar;19(1):20-7. doi: 10.1097/PDM.0b013e3181ad5ac3.

PMID:
20186008
6.

Use of guanylyl cyclase C for detecting micrometastases in lymph nodes of patients with colon cancer.

Waldman SA, Cagir B, Rakinic J, Fry RD, Goldstein SD, Isenberg G, Barber M, Biswas S, Minimo C, Palazzo J, Park PK, Weinberg D.

Dis Colon Rectum. 1998 Mar;41(3):310-5.

PMID:
9514425
7.
8.

Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients.

Conzelmann M, Dieterle CP, Linnemann U, Berger MR.

Int J Cancer. 2003 Nov 20;107(4):617-28.

PMID:
14520701
9.

Detection of occult metastasis in lymph nodes from colorectal cancer patients: a multiple-marker reverse transcriptase-polymerase chain reaction study.

Chen G, McIver CM, Texler M, Lloyd JM, Rieger N, Hewett PJ, Sen Wan D, Hardingham JE.

Dis Colon Rectum. 2004 May;47(5):679-86. Epub 2004 Mar 25.

PMID:
15037935
10.

Heterogeneity of guanylyl cyclase C expressed by human colorectal cancer cell lines in vitro.

Waldman SA, Barber M, Pearlman J, Park J, George R, Parkinson SJ.

Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):505-14.

11.

Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.

Bernini A, Spencer M, Frizelle S, Madoff RD, Willmott LD, McCormick SR, Niehans GA, Ho SB, Kratzke RA.

Cancer Detect Prev. 2000;24(1):72-9.

PMID:
10757125
12.

Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS.

Oberg AN, Lindmark GE, Israelsson AC, Hammarström SG, Hammarström ML.

Int J Cancer. 2004 Aug 10;111(1):101-10.

PMID:
15185350
13.

Previstage GCC test for staging patients with colorectal cancer.

Mejia A, Waldmana SA.

Expert Rev Mol Diagn. 2008 Sep;8(5):571-8. doi: 10.1586/14737159.8.5.571.

14.

Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood.

Fava TA, Desnoyers R, Schulz S, Park J, Weinberg D, Mitchell E, Waldman SA.

J Clin Oncol. 2001 Oct 1;19(19):3951-9.

PMID:
11579116
15.

Detection of disseminated tumor cells in the lymph nodes of colorectal cancer patients using a real-time polymerase chain reaction assay.

Lotspeich E, Schoene M, Gerngross H, Schmidt R, Steinmann R, Ramadani M, Gansauge S.

Langenbecks Arch Surg. 2007 Sep;392(5):559-66. Epub 2007 Apr 25.

PMID:
17457603
16.

Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis.

Sargent DJ, Resnick MB, Meyers MO, Goldar-Najafi A, Clancy T, Gill S, Siemons GO, Shi Q, Bot BM, Wu TT, Beaudry G, Haince JF, Fradet Y.

Ann Surg Oncol. 2011 Nov;18(12):3261-70. doi: 10.1245/s10434-011-1731-2. Epub 2011 May 1.

PMID:
21533822
17.

Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker.

Nosotti M, Falleni M, Palleschi A, Pellegrini C, Alessi F, Bosari S, Santambrogio L.

Chest. 2005 Sep;128(3):1539-44.

PMID:
16162755
18.

GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients.

Mejia A, Schulz S, Hyslop T, Weinberg DS, Waldman SA.

Expert Rev Mol Diagn. 2009 Nov;9(8):777-85. doi: 10.1586/erm.09.67.

19.

Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen.

Ho SB, Hyslop A, Albrecht R, Jacobson A, Spencer M, Rothenberger DA, Niehans GA, D'Cunha J, Kratzke RA.

Clin Cancer Res. 2004 Sep 1;10(17):5777-84.

20.

Molecular staging estimates occult tumor burden in colorectal cancer.

Mejia A, Schulz S, Hyslop T, Weinberg DS, Waldman SA.

Adv Clin Chem. 2010;52:19-39.

PMID:
21275338
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk